Does lower morning cortisol reflect reduced HPA-axis output and shared adrenal steroid production?

HPA-Axis Activity and Morning Cortisol

Morning cortisol levels serve as a robust biological indicator of basal hypothalamic-pituitary-adrenal (HPA) axis activity and total daily hormone output. Salivary cortisol reflects the free, biologically active fraction of the hormone, making morning salivary measurements a direct readout of HPA-axis output that is unaffected by changes in binding globulins. These morning concentrations correlate strongly with adrenal sensitivity and the overall responsiveness of the HPA system.

In clinical assessment, suppressed or low morning cortisol values are highly valuable for identifying states of reduced HPA-axis output, such as central adrenal insufficiency or iatrogenic HPA suppression. While intermediate values often fall into a diagnostic "grey zone" requiring dynamic stimulation testing, very low morning cortisol cutoffs demonstrate high specificity for ruling in adrenal hypoactivity:

• Serum Cortisol Thresholds: Morning serum cortisol levels below thresholds like 126.4 nmol/L or 160 nmol/L exhibit high specificity (ranging from 91% to nearly 99%) for confirming a deficient HPA-axis response.
• Cortisol Awakening Response (CAR): A blunted morning CAR serves as a key marker of reduced dynamic range and overall HPA-axis dysregulation.

Shared Adrenal Steroidogenic Pathways

The adrenal cortex houses the complex enzymatic machinery and shared biochemical pathways necessary to synthesize distinct classes of steroid hormones. Cortisol and adrenal androgens—such as dehydroepiandrosterone (DHEA) and androstenedione—are co-produced within this gland from a common pool of upstream precursors, demonstrating the highly integrated nature of adrenal steroidogenesis.

• Foundational Precursor: All adrenal steroidogenesis initiates with the transport of cholesterol into the mitochondria, where it is cleaved by CYP11A1 to yield pregnenolone, the universal foundational precursor.
• Shared Branch Point: Pregnenolone is hydroxylated by the dual-function enzyme CYP17A1 at the C-17 position, creating 17-hydroxypregnenolone, which serves as the critical, shared junction point for downstream pathways.
• Cortisol Production: In the zona fasciculata, 17-hydroxypregnenolone is converted by 3β-hydroxysteroid dehydrogenase type 2 (3βHSD2) to 17-hydroxyprogesterone, which then undergoes sequential hydroxylations via CYP21A2 and CYP11B1 to yield active cortisol.
• Adrenal Androgen Production: In the zona reticularis, where 3βHSD2 expression is low but cytochrome b5 is highly expressed, CYP17A1 acts via its 17,20-lyase activity to cleave 17-hydroxypregnenolone directly into DHEA, which can be sulfated to DHEAS or converted to androstenedione.

Bottom line

• Morning cortisol levels strongly reflect overall HPA-axis output, with distinctly low morning values (e.g., serum cortisol below 126.4 nmol/L) serving as highly specific clinical markers for HPA hypoactivity. Furthermore, the adrenal cortex produces both cortisol and adrenal androgens from shared steroidogenic pathways utilizing the common precursors cholesterol, pregnenolone, and 17-hydroxypregnenolone before branching under zonal enzymatic control.